UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

FADD adaptor and PEA-15/ERK1/2 partners in major depression and schizophrenia postmortem brains: Basal contents and effects of psychotropic treatments

Neuroscience, 2014-09, Vol.277, p.541-551

2014

Volltextzugriff (PDF)

Visual dysfunction and its correlation with retinal changes in patients with Parkinson's disease: an observational cross-sectional study

BMJ open, 2016-05, Vol.6 (5), p.e009658-e009658

2016

Volltextzugriff (PDF)

Use of Fourier-domain OCT to detect retinal nerve fiber layer degeneration in Parkinson's disease patients

Eye (London), 2013-04, Vol.27 (4), p.507-514

2013

Volltextzugriff (PDF)

Gene expression patterns in brain cortex of three different animal models of depression

Genes, brain and behavior, 2008-08, Vol.7 (6), p.649-658

2008

Volltextzugriff (PDF)

Camptocormia as the main manifestation of a mutation in the POLG gene

Neurología (Barcelona, English ed. ), 2021-06, Vol.36 (5), p.390-392

2021

Volltextzugriff (PDF)

The inverse agonist effect of rimonabant on G protein activation is not mediated by the cannabinoid CB1 receptor: Evidence from postmortem human brain

Biochemical pharmacology, 2012-01, Vol.83 (2), p.260-268

2012

Volltextzugriff (PDF)

Update on visual function and choroidal-retinal thickness alterations in Parkinson's disease

Archivos de la Sociedad Española de Oftalmología (English ed.), 2018-05, Vol.93 (5), p.231-238

2018

Volltextzugriff (PDF)

Influencia de la estimulación cerebral profunda en la carga de cuidadores de pacientes con enfermedad de Parkinson

Neurología (Barcelona, Spain), 2018-04, Vol.33 (3), p.154-159

2018

Volltextzugriff (PDF)

Actualización sobre alteraciones de función visual y espesores coriorretinianos en la enfermedad de Parkinson

Archivos de la Sociedad Española de Oftalmología, 2018-05, Vol.93 (5), p.231-238

2018

Volltextzugriff (PDF)

P.3.a.001 Selective up-regulation of serotonin 5-HT2A receptor coupling to Gαi1 -proteins in postmortem brain of subjects with schizophrenia

European neuropsychopharmacology, 2014-10, Vol.24, p.S483-S484

2014

Volltextzugriff (PDF)

Update on visual function and choroidal–retinal thickness alterations in Parkinson's disease

Archivos de la Sociedad Española de Oftalmología (English ed.), 2018-05, Vol.93 (5), p.231-238

2018

Volltextzugriff (PDF)

P.1.g.022 Hallucinogenic and non-hallucinogenic 5-HT2A receptor agonists induce distinct patterns of G protein coupling in postmortem human brain

European neuropsychopharmacology, 2013-10, Vol.23, p.S201-S201

2013

Volltextzugriff (PDF)

P.1.g.031 Functional coupling of group II metabotropic glutamate receptors to Gα-proteins in postmortem frontal cortex of schizophrenic subjects

European neuropsychopharmacology, 2013-10, Vol.23, p.S206-S207

2013

Volltextzugriff (PDF)

P.0609 Increased serotonin 5HT2A receptor constitutive activity on Gαi1- but not Gαq/11-proteins in human prefrontal cortex of subjects with schizophrenia

European neuropsychopharmacology, 2021-12, Vol.53, p.S447-S448

2021

Volltextzugriff (PDF)

Cannabinoid system in the budgerigar brain

Brain research, 2006-05, Vol.1087 (1), p.105-113

2006

Volltextzugriff (PDF)

P.115 Functional selectivity of different serotonin 5-HT2A receptor antagonists in human post-mortem brain cortex

European neuropsychopharmacology, 2020-02, Vol.31, p.S11-S12

2020

Volltextzugriff (PDF)

P.089 Pimavanserin behaves as serotonin 5-HT2A receptor inverse agonist selective for gαi/o but not gαq/11 proteins in human prefrontal cortex

European neuropsychopharmacology, 2019-12, Vol.29, p.S78-S79

2019

Volltextzugriff (PDF)

P.0907 Cannabis abuse differently regulates 5-HT2A receptors and Akt protein in platelets of subjects with schizophrenia

European neuropsychopharmacology, 2021-12, Vol.53, p.S666-S667

2021

Volltextzugriff (PDF)

Deep brain stimulation for patients with Parkinson's disease: Effect on caregiver burden

Neurología (Barcelona, English ed. ), 2018-04, Vol.33 (3), p.154-159

2018

Volltextzugriff (PDF)

Deep brain stimulation for patients with Parkinson's disease: Effect on caregiver burden

Neurologia (Barcelona, Spain), 2018-04, Vol.33 (3), p.154-159

2018

Volltextzugriff (PDF)

Pharmacological characterization and autoradiographic distribution of α2-adrenoceptor antagonist [3H]RX 821002 binding sites in the chicken brain

Neuroscience, 2006, Vol.141 (1), p.357-369

2006

Volltextzugriff (PDF)

P.6.b.002 Cannabinoid CB1 receptor protein expression in postmortem brain of suicidal and non-suicidal alcoholic subjects

European neuropsychopharmacology, 2008, Vol.18, p.S527-S528

2008

Volltextzugriff (PDF)

P.1.08 Alterations in α2A-adrenoceptor mediated G-protein signalling in postmortem prefrontal cortex of schizophrenia subjects

European neuropsychopharmacology, 2019, Vol.29, p.S638-S639

2019

Volltextzugriff (PDF)

Decreased ribosomal protein S6 phosphorylation in post-mortem prefrontal cortex of subjects with schizophrenia: Effects of antipsychotic treatment

European neuropsychopharmacology, 2019, Vol.29, p.S321-S321

2019

Volltextzugriff (PDF)

Síndrome de vena cava superior como complicación del tratamiento con inmunoglobulinas intravenosas

Neurología (Barcelona, Spain), 2017-04, Vol.32 (3), p.202-204

2017

Volltextzugriff (PDF)

1 – 25 von 94

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(90)
Mit Volltextzugriff
(85)

Publikationsform

Artikel
(94)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

FADD adaptor and PEA-15/ERK1/2 partners in major depression and schizophrenia postmortem brains: Basal contents and effects of psychotropic treatments

Visual dysfunction and its correlation with retinal changes in patients with Parkinson's disease: an observational cross-sectional study

Use of Fourier-domain OCT to detect retinal nerve fiber layer degeneration in Parkinson's disease patients

Gene expression patterns in brain cortex of three different animal models of depression

Camptocormia as the main manifestation of a mutation in the POLG gene

The inverse agonist effect of rimonabant on G protein activation is not mediated by the cannabinoid CB1 receptor: Evidence from postmortem human brain

Update on visual function and choroidal-retinal thickness alterations in Parkinson's disease

Influencia de la estimulación cerebral profunda en la carga de cuidadores de pacientes con enfermedad de Parkinson

Actualización sobre alteraciones de función visual y espesores coriorretinianos en la enfermedad de Parkinson

P.3.a.001 Selective up-regulation of serotonin 5-HT2A receptor coupling to Gαi1 -proteins in postmortem brain of subjects with schizophrenia

Update on visual function and choroidal–retinal thickness alterations in Parkinson's disease

P.1.g.022 Hallucinogenic and non-hallucinogenic 5-HT2A receptor agonists induce distinct patterns of G protein coupling in postmortem human brain

P.1.g.031 Functional coupling of group II metabotropic glutamate receptors to Gα-proteins in postmortem frontal cortex of schizophrenic subjects

P.0609 Increased serotonin 5HT2A receptor constitutive activity on Gαi1- but not Gαq/11-proteins in human prefrontal cortex of subjects with schizophrenia

Cannabinoid system in the budgerigar brain

P.115 Functional selectivity of different serotonin 5-HT2A receptor antagonists in human post-mortem brain cortex

P.089 Pimavanserin behaves as serotonin 5-HT2A receptor inverse agonist selective for gαi/o but not gαq/11 proteins in human prefrontal cortex

P.0907 Cannabis abuse differently regulates 5-HT2A receptors and Akt protein in platelets of subjects with schizophrenia

Deep brain stimulation for patients with Parkinson's disease: Effect on caregiver burden

Deep brain stimulation for patients with Parkinson's disease: Effect on caregiver burden

Pharmacological characterization and autoradiographic distribution of α2-adrenoceptor antagonist [3H]RX 821002 binding sites in the chicken brain

P.6.b.002 Cannabinoid CB1 receptor protein expression in postmortem brain of suicidal and non-suicidal alcoholic subjects

P.1.08 Alterations in α2A-adrenoceptor mediated G-protein signalling in postmortem prefrontal cortex of schizophrenia subjects

Decreased ribosomal protein S6 phosphorylation in post-mortem prefrontal cortex of subjects with schizophrenia: Effects of antipsychotic treatment

Síndrome de vena cava superior como complicación del tratamiento con inmunoglobulinas intravenosas

Suchergebnisse filtern